Riskpilot← Back to searchSign inGet full accessSEVILHAUG FYSIOTERAPI OG MANUELLTERAPI AS
ASActiveOrg 918136959Landmovegen 5A, 2870 DokkaPhysiotherapy activities · NACE 8695Est. 20162 employees
Revenue 2025
NOK 924K
-5% vs 2024
EBITDA margin
9.2%
-45% vs 2024
Equity ratio
79.3%
Financial strength
Net profit 2025
NOK 50K
-51% vs 2024
| Revenue | NOK 924K | -5% |
| EBITDA | NOK 85K | -45% |
| Net profit | NOK 50K | -51% |
| Total assets | NOK 318K | +0% |
| Equity | NOK 252K | +25% |
| Employees | 2 | — |
Legal name
SEVILHAUG FYSIOTERAPI OG MANUELLTERAPI AS
Org number
918136959
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
12. desember 2016
Share capital
NOK 40 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Fysioterapi, trening og manuellterapi og tjenester som naturlig hører sammen med dette.
Address
Landmovegen 5A, 2870 Dokka
Phone
+4761110470
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 931 | 929 | 944 | 968 | 924 |
| Staff expenses | −72 | −44 | −54 | −52 | −37 |
| EBITDA | 69 | 66 | 144 | 154 | 85 |
| Depreciation & amort. | −18 | −9 | −14 | −23 | −20 |
| EBIT | 51 | 58 | 130 | 132 | 65 |
| Net financials | −13 | −5 | 0 | −2 | 1 |
| Profit before tax | 39 | 53 | 130 | 130 | 66 |
| Tax | −0 | −0 | 18 | 29 | 16 |
| Net profit | 39 | 53 | 112 | 101 | 50 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 132 | 118 | 312 | 319 | 318 |
| Equity | −65 | −12 | 101 | 202 | 252 |
| Long-term debt | 0 | 0 | 1 | 0 | 0 |
| Short-term debt | 196 | 129 | 210 | 117 | 66 |
| Total debt | 196 | 129 | 212 | 117 | 66 |
EBITDA margin
9.2%
This company
15.8%
Market median
-42% vs market
20212025
Equity ratio
79.3%
This company
38.2%
Market median
+108% vs market
20212025
Return on equity
19.8%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
5.4%
This company
8.1%
Market median
-33% vs market
20212025
Asset turnover
2.91×
This company
1.12×
Market median
+160% vs market
20212025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
VS Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2016 | |
| Board of Directors | 2016 | |
| Board of Directors | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SEVILHAUG FYSIOTERAPI OG MANUELLTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vegard Sevilhaug | Chief Executive Officer | 0 companies |
| Karen Therese Kojedal | Board of Directors | 0 companies |
| Sondre Johannes Lihovd | Board of Directors | 0 companies |
| Gunn Marit Øistad | Board of Directors | 0 companies |